Clinical trial
Vaccination for the Treatment of Previously Untreated or Relapsed Follicular…
NCT00487305 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00487305 |
|---|---|
| Title | Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma |
| Official title | A Phase I Trial of Vaccination With Lethally Irradiated Lymphoma Cells Admixed With Granulocyte-Macrophage Colony Stimulating Factor Secreting K562 Cells for the Treatment of Previously Untreated or Relapses Follicular Lymphoma |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Follicular Lymphoma |
| Intervention type | Biological |
| Interventions | Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells |
| Enrollment | 24 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 25, 2023 |
| Completion | Jul 25, 2023 |
| First posted | Jun 18, 2007 |
| Last update posted | Aug 15, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: